Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 202
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neuropharmacology ; 26(12): 1733-7, 1987 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3437939

RESUMEN

Electroconvulsive shock-induced changes in the intensity of stereotype induced by apomorphine, the binding of [3H]spiroperidol in the corpus striatum, the accumulation of [3H]dopamine in brain and the permeability of the blood-brain barrier, were monitored in rats 30 min after single, or 24 hr after chronic (once daily for 7 days) electroconvulsive shock. There was significant potentiation in stereotypy induced by apomorphine after chronic electroconvulsive shock. The binding of [3H]spiroperidol did not show any change in the affinity (Kd) or density (Bmax) of receptors in the striatum after acute or chronic electroconvulsive shock. The accumulation of dopamine increased significantly in the hypothalamus after acute electroconvulsive shock and in the corpus striatum and hypothalamus after chronic electroconvulsive shock. A significant increase in the entry of sodium fluorescein into the hypothalamus occurred after acute electroconvulsive shock; it increased in all the regions of the brain after chronic electroconvulsive shock. Alteration in the blood-brain barrier (BBB) by electroconvulsive shock leading to increased accumulation of dopamine in the corpus striatum may be responsible for the potentiation of stereotypy.


Asunto(s)
Apomorfina/farmacología , Electrochoque , Convulsiones/psicología , Conducta Estereotipada/efectos de los fármacos , Animales , Barrera Hematoencefálica/efectos de los fármacos , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Masculino , Ratas , Receptores Dopaminérgicos/efectos de los fármacos , Receptores Dopaminérgicos/metabolismo , Espiperona/metabolismo , Espiperona/farmacología
2.
Neuropharmacology ; 24(9): 909-13, 1985 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-4058681

RESUMEN

The permeability of the blood-brain barrier was assessed in the cat, using Evan's blue as circulant. Regional blood flow and vascular resistance in various areas of brain were measured using radioactive microspheres. Cardiac output (CO), blood pressure (BP), heart rate (HR), pH, pO2 and pCO2 were also measured. Hypertonic saline (5 M, 0.5 ml/kg), administered intravenously, increased the staining of the brain substance. It also produced a marked increase in cerebral blood flow after 5 min and a marked decrease in blood flow to all the regions of the brain after 20 min. The flow returned to normal after 40 min. The vascular resistance decreased at 5 min, increased at 20 min and returned to normal at 40 min. Cardiac output increased significantly at 5 min and decreased at 20 min, while at 40 min it returned to normal. Blood pressure decreased at 5 min, increased at 20 min, while heart rate steadily decreased. A complete recovery of cardiac output, blood pressure and heart rate occurred in 1 hr. No change was observed in pH, pCO2 and pO2. It is concluded that intravenous administration of hypertonic saline causes marked haemodynamic changes and increases the permeability of the blood-brain barrier due to transient impairment of autoregulation.


Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Cloruro de Sodio/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Arterias Carótidas , Gatos , Circulación Cerebrovascular/efectos de los fármacos , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Inyecciones Intraarteriales , Inyecciones Intravenosas , Masculino , Solución Salina Hipertónica , Resistencia Vascular/efectos de los fármacos
3.
Immunol Lett ; 25(1-3): 53-7, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2126528

RESUMEN

Earlier, we reported that prophylactic treatment with human interferon gamma (rHuIFN-gamma) protected monkeys against Plasmodium cynomolgi B malaria infection. We have tested the efficacy of rHuIFN-gamma on relapsing stage of experimental P. cynomolgi B malaria infection in rhesus monkeys. No effect of rHuIFN-gamma was seen against experimental relapsing stage compared with controls; however, it appears that chloroquine (CHL) may have interfered with the antimalarial effect of IFN, since treatment with CHL inhibits the antiviral activity of mouse alpha/beta IFN and polyinosinic-polycytidylic acid (poly I:C) against Semliki forest virus (SFV) in mice. These results may have clinical implications especially with the use of IFN against virus infection, cancer and in parasitic infections in malaria endemic areas where CHL is one of the most widely used antimalarial drugs. Our result also shows that CHL treatment enhances the virus replication in mice and suggest a possible connection between AIDS and malaria infection, since the spread of AIDS has been rapid in parts of tropical Africa that have a high incidence of malaria, and chloroquine has been frequently used in the chemotherapy of malaria.


Asunto(s)
Interferón gamma/uso terapéutico , Malaria/tratamiento farmacológico , Animales , Antivirales/antagonistas & inhibidores , Cloroquina/farmacología , Femenino , Interferón Tipo I/antagonistas & inhibidores , Interferón gamma/antagonistas & inhibidores , Macaca mulatta , Masculino , Ratones , Ratones Endogámicos BALB C , Mitógenos/antagonistas & inhibidores , Poli I-C/antagonistas & inhibidores , Proteínas Recombinantes , Recurrencia
4.
Br J Pharmacol ; 40(2): 237-48, 1970 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-4395376

RESUMEN

1. Effects of some alpha- and beta-adrenoceptor stimulants and antagonists were investigated on flexor reflex (FR) in chloralosed cats.2. Noradrenaline (NA) produced facilitation of FR which was dose-dependent and reproducible and was blocked by alpha-adrenoceptor blocking agents.3. Strychnine also produced facilitation of FR but the response was unaffected by alpha-adrenoceptor blocking agents.4. Metaraminol and alpha-methyl-noradrenaline had little effect on FR but blocked the NA response.5. beta-adrenoceptor stimulants and antagonists had neither any effect on FR nor modified the NA response.6. Vasopressin and histamine also failed to modify FR.7. Possibility of alpha-adrenoceptors in the neurones integrating FR is suggested.


Asunto(s)
Catecolaminas/farmacología , Reflejo/efectos de los fármacos , Antagonistas Adrenérgicos alfa/farmacología , Antagonistas Adrenérgicos beta/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Gatos , Histamina/farmacología , Inyecciones Espinales , Lidocaína/farmacología , Masculino , Metaraminol/farmacología , Norepinefrina/farmacología , Receptores de Droga , Nervio Ciático/efectos de los fármacos , Estricnina/farmacología , Vasopresinas/farmacología
5.
Br J Pharmacol ; 43(3): 497-503, 1971 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-4400526

RESUMEN

1. The effects of intracerebroventricular administration of some alpha- and beta-adrenoceptor stimulants and antagonists on the body temperature of rabbits were investigated.2. Noradrenaline produced a dose dependent rise in body temperature. Other catecholamines were less active.3. The noradrenaline response was blocked by alpha-adrenoceptor blocking agents while beta-adrenoceptor antagonists had no effect.4. alpha-Methyl-noradrenaline and metaraminol had some hyperthermic effect, but significantly reduced the response of noradrenaline.5. The possible presence of alpha-adrenoceptors in the central thermoregulatory mechanisms is suggested.


Asunto(s)
Regulación de la Temperatura Corporal , Norepinefrina/farmacología , Receptores de Droga , Antagonistas Adrenérgicos beta/farmacología , Amino Alcoholes/farmacología , Anilidas/farmacología , Animales , Regulación de la Temperatura Corporal/efectos de los fármacos , Ventrículos Cerebrales , Dibencilcloretamina/farmacología , Dopamina/farmacología , Epinefrina/farmacología , Inyecciones , Metaraminol/farmacología , Nitrobencenos/farmacología , Normetanefrina/farmacología , Conejos , Receptores Adrenérgicos , Ácidos Sulfónicos/farmacología , Tolazolina/farmacología
6.
Br J Pharmacol ; 49(1): 64-73, 1973 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-4787565

RESUMEN

1. Anti-inflammatory, analgesic, antipyretic and other pharmacological activities of a new chroman derivative, Centchroman, have been described.2. Centchroman was found to possess significant anti-inflammatory action in the carrageenin-induced oedema test in mice and rats. It inhibited granuloma formation in the cotton pellet test. The anti-arthritic activity was also evident in formaldehyde-induced arthritis and adjuvant-induced arthritis in rats.3. Centchroman had a lower ulcerogenic index than phenylbutazone.4. The mechanism of the anti-inflammatory action of Centchroman seemed to be independent of endogenous adrenocortical hormones or of its weak oestrogenic activity.5. Centchroman antagonized phenylquinone writhing and bradykinin-induced bronchospasm but was devoid of any antipyretic activity.


Asunto(s)
Antiinflamatorios/farmacología , Benzopiranos/farmacología , Pirrolidinas/farmacología , Glándulas Suprarrenales/efectos de los fármacos , Analgesia , Animales , Artritis/prevención & control , Benzopiranos/uso terapéutico , Benzopiranos/toxicidad , Presión Sanguínea/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Bradiquinina/antagonistas & inhibidores , Espasmo Bronquial/prevención & control , Gatos , Edema/prevención & control , Femenino , Granuloma/prevención & control , Cobayas , Íleon/efectos de los fármacos , Masculino , Ratones , Músculo Liso/efectos de los fármacos , Membrana Nictitante/efectos de los fármacos , Éteres Fenílicos/farmacología , Éteres Fenílicos/uso terapéutico , Éteres Fenílicos/toxicidad , Pirrolidinas/uso terapéutico , Pirrolidinas/toxicidad , Quinonas/antagonistas & inhibidores , Ratas , Úlcera Gástrica/inducido químicamente
7.
Br J Pharmacol ; 75(1): 145-9, 1982 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7074279

RESUMEN

1 The effect of intracerebroventricular (i.c.v.) injection of histamine on the rectal temperature of Mastomys natalensis at ambient temperatures of 10, 24 and 33 degrees C has been studied. 2 Low doses (0.1-1.0 microgram) of histamine produced hypothermia while larger doses (5-20 micrograms) produced dose-dependent hyperthermia. The hypothermic effect was significantly antagonized by mepyramine while the hyperthermia was blocked by cimetidine. 3 Histamine H1-receptor agonists, 2-methyl-histamine and 2-pyridyl-ethylamine, also produced hypothermia which could be blocked by mepyramine. 4 Histamine H2-receptor agonists, impromidine and dimaprit, produced hyperthermia which was antagonized by cimetidine. 5 Pretreatment of the animals with a beta-adrenoceptor antagonist, MJ1999, did not affect the response to histamine. 6 The hyperthermic effect of histamine (10 micrograms) was most marked at 10 degrees C and was attenuated at 33 degrees C. 7 It is concluded that both H1 and H2-histamine receptors are present in the brain of Mastomys. The H1-receptors mediate hypothermia and H2-receptors hyperthermia.


Asunto(s)
Regulación de la Temperatura Corporal/efectos de los fármacos , Muridae/fisiología , Receptores Histamínicos H1/fisiología , Receptores Histamínicos H2/fisiología , Receptores Histamínicos/fisiología , Animales , Relación Dosis-Respuesta a Droga , Femenino , Histamina/farmacología , Antagonistas de los Receptores Histamínicos/farmacología , Masculino , Receptores Histamínicos H1/efectos de los fármacos , Receptores Histamínicos H2/efectos de los fármacos
8.
Br J Pharmacol ; 44(3): 404-12, 1972 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-4339248

RESUMEN

1. The effects of intracerebroventricular or intrathecal administration of glycine on some somatic reflexes in chloralosed cats were investigated.2. Glycine produced marked inhibition of the flexor reflex (FR) and crossed extensor reflex (CER) at low doses (2.5-5.0 mg) but even large doses (up to 40.0 mg) had no effect on the facilitation or inhibition of the patellar reflex produced by stimulation of either the reticular formation or the sciatic nerve. The linguomandibular reflex (LMR) could be blocked by 10-20 mg glycine.3. Glycine antagonized strychnine-induced facilitation of FR, CER and LMR and was 5-6 times as active as gamma-aminobutyric acid in this respect.4. The possibility of glycine being a transmitter in spinal pathways is discussed.


Asunto(s)
Glicina/farmacología , Reflejo/efectos de los fármacos , Aminobutiratos/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Gatos , Depresión Química , Reflejo Monosináptico/efectos de los fármacos , Formación Reticular/fisiología , Nervio Ciático/fisiología , Estricnina/antagonistas & inhibidores , Transmisión Sináptica
9.
Br J Pharmacol ; 54(1): 17-21, 1975 May.
Artículo en Inglés | MEDLINE | ID: mdl-1139074

RESUMEN

1. The effect of clonidine on the direct excitability of hypothalamic, medullary and spinal vasomotor loci has been investigated in cats anaesthetized with chloralose. 2. Clonidine inhibited the excitability of these loci when it was localized to the central sites by intracerebroventricular, intravertebral arterial or intrathecal injection in very low doses (1-2 mug). 3. Topical application of clonidine (0.01 percent and 1.0 percent) to the floor of the fourth ventricle inhibited pressor responses evoked either by stimulation of medullary or hypothalamic vasomotor areas. Inhibition of the pressor responses was accompanied by hypotension and bradycardia in many experiments. 4. It appears that effects of clonidine on the vasomotor loci of the medulla oblongata and the spinal cord contribute to its hypotensive action.


Asunto(s)
Clonidina/farmacología , Hipotálamo/efectos de los fármacos , Bulbo Raquídeo/efectos de los fármacos , Nervios Espinales/efectos de los fármacos , Sistema Vasomotor/efectos de los fármacos , Administración Tópica , Animales , Presión Sanguínea/efectos de los fármacos , Gatos , Cloralosa/farmacología , Clonidina/administración & dosificación , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Inyecciones , Inyecciones Intraarteriales , Masculino , Presorreceptores/efectos de los fármacos
10.
Biochem Pharmacol ; 44(1): 180-3, 1992 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-1321626

RESUMEN

Picroliv, the active principle of Picrorhiza kurrooa, and its main components which are a mixture of the iridoid glycosides, picroside-I and kutkoside, were studied in vitro as potential scavengers of oxygen free radicals. The superoxide (O2-) anions generated in a xanthine-xanthine oxidase system, as measured in terms of uric acid formed and the reduction of nitroblue tetrazolium were shown to be suppressed by picroliv, picroside-I and kutkoside. Picroliv as well as both glycosides inhibited the non-enzymic generation of O2- anions in a phenazine methosulphate NADH system. Malonaldehyde (MDA) generation in rat liver microsomes as stimulated by both the ascorbate-Fe2+ and NADPH-ADP-Fe2+ systems was shown to be inhibited by the Picroliv glycosides. Known antioxidants tocopherol (vitamin E) and butylated hydroxyanisole (BHA) were also compared with regard to their antioxidant actions in the above system. It was found that BHA afforded protection against ascorbate-Fe(2+)-induced MDA formation in microsomes but did not interfere with enzymic or non-enzymic O2- anion generation; and tocopherol inhibited lipid peroxidation in microsomes by both prooxidant systems and the generation of O2- anions in the non-enzymic system but did not interfere with xanthine oxidase activity. The present study shows that picroliv, picroside-I and kutkoside possess the properties of antioxidants which appear to be mediated through activity like that of superoxide dismutase, metal ion chelators and xanthine oxidase inhibitors.


Asunto(s)
Cinamatos/farmacología , Depuradores de Radicales Libres , Glicósidos/farmacología , Extractos Vegetales/farmacología , Superóxidos/química , Ácido Vanílico/farmacología , Animales , Peroxidación de Lípido/efectos de los fármacos , Malondialdehído/metabolismo , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Ratas , Vitamina E/farmacología , Xantina Oxidasa/metabolismo
11.
Neuroreport ; 4(7): 944-6, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8369486

RESUMEN

The study was aimed to delineate the neurotransmitter receptors involved in pretectal analgesic mechanisms by direct microinjection of neurotransmitter agonists and antagonists through chronically implanted cannulae in the pretectal nucleus of rats. Morphine, clonidine and serotonin, at doses of 2.5 and 5.0 micrograms microinjected into the pretectal nucleus, produced a significant and prolonged analgesia as measured by the tail-flick test. The analgesia produced by morphine, clonidine and serotonin is significantly attenuated by pretreatment of the animals with naloxone (1 micrograms), yohimbine (5 micrograms) and methysergide (5-10 micrograms) respectively. The results indicate the possible involvement of opioid, adrenergic and serotonergic mechanisms in pretectal analgesia.


Asunto(s)
Analgésicos/farmacología , Clonidina/farmacología , Morfina/farmacología , Serotonina/farmacología , Animales , Clonidina/administración & dosificación , Clonidina/antagonistas & inhibidores , Masculino , Metisergida/farmacología , Microinyecciones , Morfina/administración & dosificación , Morfina/antagonistas & inhibidores , Naloxona/farmacología , Dimensión del Dolor/efectos de los fármacos , Ratas , Serotonina/administración & dosificación , Colículos Superiores/fisiología , Yohimbina/farmacología
12.
Neuroreport ; 3(7): 591-3, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1421114

RESUMEN

Mild and brief electrical stimulation of sites in the pretectal nucleus (PTN) of rats evoked potent analgesia of long duration, without significant aversions and was unassociated with motor deficit. The present study has analysed effects of opioidergic and cholinergic neurotransmitter antagonists administered intracerebroventricularly (i.c.v.) on this analgesia. Pretreatment either with naloxone or atropine sulphate both in doses of 30 and 50 micrograms each, respectively i.c.v., 10 min prior to subsequent pretectal stimulation, significantly attenuated the increase in tailflick latency. The antagonism of pretectal stimulation produced analgesia (PSPA) by naloxone and atropine, raises the possibility of involvement of both endogenous opioids and cholinergic mechanisms in pretectal analgesia.


Asunto(s)
Analgesia , Atropina/farmacología , Tronco Encefálico/fisiología , Ventrículos Cerebrales/fisiología , Naloxona/farmacología , Dolor/fisiopatología , Animales , Atropina/administración & dosificación , Tronco Encefálico/efectos de los fármacos , Tronco Encefálico/fisiopatología , Ventrículos Cerebrales/efectos de los fármacos , Ventrículos Cerebrales/fisiopatología , Estimulación Eléctrica , Inyecciones Intraventriculares , Masculino , Naloxona/administración & dosificación , Ratas , Ratas Endogámicas , Factores de Tiempo
13.
Neuroreport ; 4(6): 706-8, 1993 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8102259

RESUMEN

The study was undertaken to evaluate the role of nitric oxide (NO) in pretectal (PTN)-induced analgesia in rats. Microinjection of varying concentrations of L-arginine (1 nM to 1 microM) produced a quick, long-lasting and concentration-dependent analgesic response, whereas similar concentrations of D-arginine failed to produce analgesia. Moreover pretreatment with N-nitro-L-arginine methyl ester (L-NAME, 1 microM) significantly prevented L-arginine induced analgesia. Further, pretreatment of animals with methylene blue, a known guanylate cyclase inhibitor also prevented the development of analgesia. Our study suggests that L-arginine caused production of NO, which in turn activates pretectal analgesic system involving cyclic GMP.


Asunto(s)
Mesencéfalo/fisiología , Óxido Nítrico/metabolismo , Analgesia , Animales , Arginina/administración & dosificación , Arginina/análogos & derivados , Arginina/farmacología , Guanilato Ciclasa/antagonistas & inhibidores , Masculino , Azul de Metileno/farmacología , Microinyecciones , NG-Nitroarginina Metil Éster , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Endogámicas
14.
Neuroreport ; 2(8): 449-50, 1991 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1912478

RESUMEN

The presence of opioidergic activity after i.p. injection of N-methyl-4-phenyl tetrahydropyridine (MPTP) has been investigated in albino mice by studying analgesia and the Straub reaction. MPTP (6.25-25 mg kg-1) produced a dose-related analgesic response and Straub reaction. These effects of MPTP were effectively antagonized by prior naloxone treatment but remained unaffected after the MAO-B inhibitor deprenyl. MPTP thus possesses significant opioidergic activity and this, unlike its neurotoxic actions, does not appear to be dependent on oxidative conversion to MPP+ (1-methyl-4-phenyl pyridinium).


Asunto(s)
1-Metil-4-fenil-1,2,3,6-Tetrahidropiridina/farmacología , Analgesia , Isoenzimas/metabolismo , Monoaminooxidasa/metabolismo , Narcóticos/farmacología , Selegilina/farmacología , Animales , Femenino , Masculino , Ratones , Ratones Endogámicos , Naloxona/farmacología , Postura , Valores de Referencia
15.
Am J Trop Med Hyg ; 48(5): 645-51, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8517483

RESUMEN

An oligomeric ester of prostaglandin B2 (OC-5186) was found to reverse chloroquine resistance in the murine malarial parasite Plasmodium berghei. When mice were infected with either chloroquine-sensitive or -resistant P. berghei on day 0 (by intraperitoneal injection of 1 x 10(6) parasitized erythrocytes), they died before day 23. When treated with 15 mg/kg/day of chloroquine for the first four days of infection, all mice infected with the sensitive-strain survived, while all those infected with the resistant strain died before day 23. When OC-5186 (3-12 mg/kg/day) was administered in combination with chloroquine for the first four days, 60% of the animals infected with the resistant strain survived. The differences in the survival rate between the group treated with chloroquine only and the group treated with a combination of drugs (chloroquine plus 3-12 mg/kg/day of OC-5186) were significant. There was also a significant inhibition of parasitemia in the group treated with the combination of drugs. The combinations of chloroquine and a monomer ester of prostaglandin B2 (OC-5181) had some antimalarial activity, but the differences between the chloroquine-treated group and the combination treatment group were not significant in terms of both the parasitemia and the survival rate. Another oligomeric ester of prostaglandin E1 (MR-356) as well as unesterified monomer prostaglandins (PGA2 and PGB2) were ineffective by themselves and in combination with chloroquine.


Asunto(s)
Cloroquina/uso terapéutico , Malaria/tratamiento farmacológico , Plasmodium berghei/efectos de los fármacos , Prostaglandinas B/uso terapéutico , Alprostadil/análogos & derivados , Alprostadil/farmacología , Alprostadil/uso terapéutico , Animales , Antimaláricos/farmacología , Antimaláricos/uso terapéutico , Cloroquina/farmacología , Resistencia a Medicamentos , Quimioterapia Combinada , Malaria/parasitología , Masculino , Ratones , Prostaglandinas A/farmacología , Prostaglandinas A/uso terapéutico , Prostaglandinas B/farmacología
16.
Eur J Pharmacol ; 279(1): 1-5, 1995 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-7556376

RESUMEN

There is considerable evidence that nitric oxide (NO) plays a role in synaptic transmission in both central and peripheral nervous systems. Recent studies have suggested the involvement of the L-arginine-NO pathway in nociceptive transmission/modulation. Electrical stimulation of the red nucleus in the rat evokes potent analgesia. Microinjection of different concentrations of L-arginine (1 nmol-1 mumol), but not of D-arginine, produced quick and long-lasting analgesia. Pretreatment with N-nitro-L-arginine methyl ester (1 mumol), a nitric oxide synthase inhibitor, significantly prevented L-arginine-induced analgesia. Further, pretreatment of animals with methylene blue, a known guanylate cyclase inhibitor, also attenuated the development of analgesia. Our results suggest that L-arginine caused production of NO, which in turn activated the red nucleus analgesic system.


Asunto(s)
Analgesia , Óxido Nítrico/fisiología , Núcleo Rojo/efectos de los fármacos , Animales , Arginina/análogos & derivados , Arginina/antagonistas & inhibidores , Arginina/farmacología , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Masculino , Azul de Metileno/farmacología , NG-Nitroarginina Metil Éster , Óxido Nítrico Sintasa/antagonistas & inhibidores , Ratas , Núcleo Rojo/fisiología
17.
Eur Neuropsychopharmacol ; 8(3): 195-201, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9716313

RESUMEN

Pentylenetetrazol (PTZ; 30 mg/kg, i.m.) produced an acute anxiogenic effect on the behaviour of a social colony of rhesus monkeys acclimatized to laboratory conditions. The animals exhibited hypervigilance, aggressiveness, tachypnea, piloerection and frequent change of posture and also had raised plasma cortisol levels. These effects of PTZ were antagonized by benzodiazepines (diazepam; 1 mg/kg, i.v. and alprazolam; 0.05 mg/kg, p.o.). Non-benzodiazepine anxiolytic drug (buspirone; 10 mg/kg, p.o.) blocked the behavioural effects but not the rise in plasma cortisol concentration. On the other hand, pretreatment with hypnosedative (promethazine; 5 mg/kg, i.m.) or anticonvulsant (sodium valproate; 40 mg/kg, p.o.) agents did not attenuate the effects of PTZ indicating the specificity of its anxiogenic response. The model, thus, seems suitable for evaluation of potential anxiolytic agents.


Asunto(s)
Ansiedad/inducido químicamente , Conducta Animal/efectos de los fármacos , Animales , Ansiedad/psicología , Benzodiazepinas/farmacología , Modelos Animales de Enfermedad , Hidrocortisona/sangre , Macaca mulatta , Pentilenotetrazol/farmacología
18.
Naunyn Schmiedebergs Arch Pharmacol ; 318(1): 38-42, 1981 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6120469

RESUMEN

Noradrenaline (NA), adrenaline (ADR), isoprenaline (ISO) and dopamine (DA) were given through a chronically implanted cannula in the lateral cerebral ventricle of Mastomys natalensis. Low doses of NA (0.05-0.25 microgram) reduced rectal temperature while larger doses (0.35 microgram upwards) produced dose-dependent hyperthermia. The hypothermic effect was antagonised by alpha-adrenoceptor and the hyperthermia by beta-adrenoceptor antagonists. alpha-Methyl noradrenaline produced less hyperthermia but it antagonised the hyperthermic effect of NA. Adrenaline (0.1-10 microgram) was ineffective per se but when given after tolazoline it produced hyperthermia and after propranolol it produced hypothermia. The dose-dependent hyperthermia with isoprenaline (0.1-10 microgram) was blocked by propranolol and MJ-1999. Dopamine (0.5-20 microgram) and its agonists apomorphine, amantadine and BS 9641 produced hyperthermia which was antagonised by haloperidol and pimozide but not by alpha- or beta adrenoceptor antagonists. Noradrenaline (1.0 microgram) produced hypothermia at ambient temperature of 10 degrees C and 16 degrees C. It had no effect at 20 degrees C which seems to be the thermoneutral zone for mastomys. The hyperthermic effect at 33 degrees C was less than at 24 degrees C. Dopamine (10 micrograms) response was attenuated at 33 degrees C and unaffected at other ambient temperatures. It is concluded that alpha- and beta-adrenoceptors and DA-receptors exist in the central thermoregulatory mechanism in mastomys. The alpha-receptors are concerned with lowering the body temperature whereas the beta-receptors and DA-receptors are involved in raising it.


Asunto(s)
Temperatura Corporal/efectos de los fármacos , Catecolaminas/farmacología , Antagonistas Adrenérgicos alfa/farmacología , Antagonistas Adrenérgicos beta/farmacología , Animales , Catecolaminas/administración & dosificación , Dopamina/farmacología , Femenino , Inyecciones Intraventriculares , Masculino , Muridae , Norepinefrina/farmacología , Temperatura
19.
Naunyn Schmiedebergs Arch Pharmacol ; 337(5): 572-5, 1988 May.
Artículo en Inglés | MEDLINE | ID: mdl-3412495

RESUMEN

The stereotyped behaviour was analysed in Mastomys natalensis, a species of desert rat recently introduced in laboratory practice. The components of stereotyped behaviour were similar to rat characterised by repetitive sniffing, rearing, licking, head movements and biting. Apomorphine (0.5-2.0 mg/kg), amphetamine (2.5-10 mg/kg), methylphenidate (10-30 mg/kg) and adamantanamine (10-50 mg/kg) administered intraperitoneally, induced stereotyped behaviour in dose-dependent manner. Positive response was also obtained by other drugs acting on dopamine receptors like l-dopa, GBR 12909, piribedil, tyramine, BS 9648, BS 9641 and BS 8824. Yohimbine (2 mg/kg) failed to produce any response. Apomorphine (2 mg/kg), amphetamine (10 mg/kg), methylphenidate (30 mg/kg) and piribedil (12 mg/kg) induced stereotypy which could be blocked by dopamine receptor blockers haloperidol (1 mg/kg) or pimozide (1 mg/kg) but yohimbine (2 mg/kg) an alpha adrenoceptor blocker was ineffective. Adamantanamine, piribedil and GBR 12909 enhanced the stereotypy induced by low doses of apomorphine, amphetamine and methylphenidate. The data shows that the stereotyped behaviour in Mastomys natalensis is mediated through dopaminergic mechanisms. It appears that both excitatory and inhibitory types of dopamine receptors are involved.


Asunto(s)
Muridae/fisiología , Conducta Estereotipada/efectos de los fármacos , Animales , Interacciones Farmacológicas , Masculino , Muridae/metabolismo , Receptores Dopaminérgicos/efectos de los fármacos , Simpaticolíticos/farmacología
20.
J Pharmacol Toxicol Methods ; 40(3): 173-9, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10334634

RESUMEN

Picroliv, the standardized active principle from the plant Picrorhiza kurrooa showed significant curative activity in vitro in primary cultured rat hepatocytes against toxicity induced by thioacetamide (200 microg/mL), galactosamine (400 microg/mL), and carbon tetrachloride (3 microl/mL). Activity was assessed by determining the change in hepatocyte viability and rate of oxygen uptake and other biochemical parameters (GOT, GPT, and AP). The toxic agents alone produced a 40-62% inhibition of cell viability and a reduction of biochemical parameters after 24 h of incubation at 37 degrees C which (on removal of the toxic agents) was reversed after further incubation for 48 h. Incubation of damaged hepatocytes with picroliv exhibited a concentration- (1-100 microg/mL) dependent curative effect in restoring altered viability parameters. The results warrant the use of this in vitro system as an alternative for in vivo assessment of hepatoprotective activity of new agents.


Asunto(s)
Tetracloruro de Carbono/toxicidad , Cinamatos/farmacología , Glicósidos/farmacología , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Ácido Vanílico/farmacología , Animales , Tetracloruro de Carbono/antagonistas & inhibidores , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Femenino , Galactosamina/antagonistas & inhibidores , Galactosamina/toxicidad , Hígado/enzimología , Masculino , Ratas , Tioacetamida/antagonistas & inhibidores , Tioacetamida/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA